512 related articles for article (PubMed ID: 14769811)
1. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.
Campbell DJ; Alexiou T; Xiao HD; Fuchs S; McKinley MJ; Corvol P; Bernstein KE
Hypertension; 2004 Apr; 43(4):854-9. PubMed ID: 14769811
[TBL] [Abstract][Full Text] [Related]
2. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.
Chappell MC; Pirro NT; Sykes A; Ferrario CM
Hypertension; 1998 Jan; 31(1 Pt 2):362-7. PubMed ID: 9453329
[TBL] [Abstract][Full Text] [Related]
4. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system may trigger kidney damage in NOD mice.
Colucci JA; Yuri Arita D; Sousa Cunha T; Seno Di Marco G; Vio CP; Pacheco-Silva A; Casarini DE
J Renin Angiotensin Aldosterone Syst; 2011 Mar; 12(1):15-22. PubMed ID: 20627940
[TBL] [Abstract][Full Text] [Related]
6. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
[TBL] [Abstract][Full Text] [Related]
7. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue.
Campbell DJ; Duncan AM; Kladis A
Hypertension; 1999 Aug; 34(2):171-5. PubMed ID: 10454436
[TBL] [Abstract][Full Text] [Related]
9. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
[TBL] [Abstract][Full Text] [Related]
10. Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene.
Wei CC; Tian B; Perry G; Meng QC; Chen YF; Oparil S; Dell'Italia LJ
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2254-8. PubMed ID: 12003835
[TBL] [Abstract][Full Text] [Related]
11. Novel roles of the renal angiotensin-converting enzyme.
Giani JF; Veiras LC; Shen JZY; Bernstein EA; Cao D; Okwan-Duodu D; Khan Z; Gonzalez-Villalobos RA; Bernstein KE
Mol Cell Endocrinol; 2021 Jun; 529():111257. PubMed ID: 33781839
[TBL] [Abstract][Full Text] [Related]
12. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell DJ; Kladis A; Duncan AM
Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
Tom B; Dendorfer A; Danser AH
Int J Biochem Cell Biol; 2003 Jun; 35(6):792-801. PubMed ID: 12676166
[TBL] [Abstract][Full Text] [Related]
15. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
[TBL] [Abstract][Full Text] [Related]
16. Angiotensinogen and angiotensin-converting enzyme gene copy number and angiotensin and bradykinin peptide levels in mice.
Alexiou T; Boon WM; Denton DA; Nicolantonio RD; Walker LL; McKinley MJ; Campbell DJ
J Hypertens; 2005 May; 23(5):945-54. PubMed ID: 15834279
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
Duncan AM; Burrell LM; Kladis A; Campbell DJ
J Cardiovasc Pharmacol; 1996 Dec; 28(6):746-54. PubMed ID: 8961071
[TBL] [Abstract][Full Text] [Related]
19. Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice.
Elased KM; Cunha TS; Marcondes FK; Morris M
Exp Physiol; 2008 May; 93(5):665-75. PubMed ID: 18263657
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice.
Hunley TE; Tamura M; Stoneking BJ; Nishimura H; Ichiki T; Inagami T; Kon V
Kidney Int; 2000 Feb; 57(2):570-7. PubMed ID: 10652034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
